🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to assess whether a new drug, Nulojix® (belat...
Status
Terminated
Location
University of Alabama
Start Date
2011-09
Trial ID
NCT01436305
Treatments Being Tested
The primary objective of the following randomized open label trial is to de...
Status
Terminated
Location
Universitary hospital of Lyon
Start Date
2014-06
Trial ID
NCT02056938
Treatments Being Tested
This study is designed to evaluate efficacity and safety of everolimus or (...
Status
Completed
Location
CHU Amiens
Start Date
2009-03
Trial ID
NCT01028092
Treatments Being Tested
The objectives of this study are to determine the efficacy and safety of BE...
Status
Terminated
Location
City of Hope Comprehensive Cancer Center
Start Date
2016-02
Trial ID
NCT02411084
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of ASKP124...
Status
Completed
Location
Site US10006
Start Date
2013-03-05
Trial ID
NCT01780844
Treatments Being Tested
The increase immunosuppression in our transplant population has led to an u...
Status
Completed
Location
University of Florida
Start Date
2007-10
Trial ID
NCT00610961
Induction therapy decreases the rate of acute allograft rejection in kidney...
Status
Recruiting
Location
01-TOURS
Start Date
2023-11-07
Trial ID
NCT05385432
Treatments Being Tested
To demonstrate that cyclosporine-sparing immunosuppressions with the standa...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01817322
IgA nephropathy (IgAN) is a histologically defined glomerulonephritis (rena...
Status
Terminated
Location
CHU de BESANCON
Start Date
2011-01-08
Trial ID
NCT02523768
To investigate the progression of the immunological response in living-dono...
Status
Completed
Location
University of California San Francisco
Start Date
2012-12
Trial ID
NCT01656135
Treatments Being Tested